日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply

应对药品监管和卫生技术评估决策中的不确定性管理:HTAi-DIA 工作组的指导意见——作者回复

Hogervorst, Milou Amber; Vreman, Rick; Heikkinen, Inkatuuli; Oortwijn, Wija

Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group

药品监管和卫生技术评估决策中的不确定性管理:HTAi-DIA 工作组指南

Hogervorst, Milou Amber; Vreman, Rick; Heikkinen, Inkatuuli; Bagchi, Indranil; Gutierrez-Ibarluzea, Inaki; Ryll, Bettina; Eichler, Hans-Georg; Petelos, Elena; Tunis, Sean; Sapede, Claudine; Goettsch, Wim; Janssens, Rosanne; Huys, Isabelle; Barbier, Liese; DeJean, Deirdre; Strammiello, Valentina; Lingri, Dimitra; Goodall, Melinda; Papadaki, Magdalini; Toussi, Massoud; Voulgaraki, Despina; Mitan, Ania; Oortwijn, Wija